Clinical Trial Update: Investigating the Minimum Number of Needling Required to Optimize Trigger Point Injections Outcome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from the University of Arizona is enrolling to determine the minimum number of needling sessions required to optimize trigger point inj…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myofascial Pain Syndrome
• Myofascial Trigger Point Pain

Snippet

Sponsor: University of Arizona | Conditions: Myofascial Pain, Myofascial Trigger Point Pain | Phase 2 | Status: ENROLLING_BY_INVITATION